NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $350,000 | -83.7% | 72,201 | -78.9% | 0.08% | -82.1% |
| Q2 2018 | $2,141,000 | -34.4% | 342,621 | -12.9% | 0.42% | -35.7% |
| Q1 2018 | $3,266,000 | +396.4% | 393,512 | +509.8% | 0.65% | +488.3% |
| Q4 2017 | $658,000 | -45.4% | 64,530 | -44.3% | 0.11% | -36.6% |
| Q3 2017 | $1,205,000 | +35.9% | 115,869 | -4.7% | 0.18% | +45.8% |
| Q2 2017 | $887,000 | +39.5% | 121,563 | +37.7% | 0.12% | +41.2% |
| Q1 2017 | $636,000 | +26.9% | 88,279 | +3.1% | 0.08% | +26.9% |
| Q4 2016 | $501,000 | +22.8% | 85,588 | +23.8% | 0.07% | +8.1% |
| Q3 2016 | $408,000 | – | 69,135 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|